Parvo preventative picks up speedDecember 29, 2020Elanco Animal Health is set to acquire the global rights to Kindred Biosciences’ proprietary KIND-030, a monoclonal antibody being developed for the treatment and prevention of canine parvovirus.
Education Center - SponsoredIntegrating Therapeutic Nutrition for Chronic Allergiesby • Hill's Pet NutritionIntended for veterinary audiences